Magenta Therapeutics, Inc. (MGTA) Social Stream
MAGENTA THERAPEUTICS INC (MGTA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MGTA.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-08 | 6 | $20 | $7 | $14.2 | $0.78 | 1720.51% |
2021-12-21 | 6 | $20 | $7.001 | $14.2 | $0.78 | 1720.51% |
2021-12-27 | 6 | $20 | $6 | $14 | $0.78 | 1694.87% |
2022-01-10 | 5 | $20 | $6 | $13.25 | $0.78 | 1598.72% |
2022-03-09 | 5 | $20 | $6 | $11.5 | $0.78 | 1374.36% |
2022-04-18 | 5 | $8 | $6 | $6.6 | $0.78 | 746.15% |
2022-05-17 | 6 | $8 | $6 | $6.666 | $0.78 | 754.62% |
2022-05-24 | 6 | $8 | $2 | $5.666 | $0.78 | 626.41% |
2022-08-04 | 4 | $8 | $2 | $5.6 | $0.78 | 617.95% |
2022-11-06 | 4 | $8 | $2 | $5.6 | $0.78 | 617.95% |
2022-12-21 | 4 | $8 | $2 | $4 | $0.78 | 412.82% |
2023-02-07 | 3 | $8 | $1 | $3.5 | $0.78 | 348.72% |
2023-03-23 | 4 | $8 | $1 | $3.5 | $0.78 | 348.72% |
2023-08-03 | 2 | $3 | $1 | $2 | $0.78 | 156.41% |
The Trend in the Analyst Price Target
MGTA's average price target has moved down $11.25 over the prior 19 months.
MGTA reports an average of 498.72% for its upside potential over the past 39 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-11-06 | 4 | 8 | 2 | 5.6 | 1.200 | 366.67% |
2022-12-21 | 5 | 8 | 2 | 4.0 | 0.362 | 1004.97% |
2022-12-21 | 4 | 8 | 2 | 4.4 | 0.362 | 1115.47% |
2023-01-26 | 4 | 8 | 1 | 3.5 | 0.440 | 695.45% |
2023-05-16 | 3 | 3 | 1 | 2.0 | 0.679 | 194.55% |
MGTA Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3 | 0 | 0 | 2 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 17 months, MGTA's average broker recommendation rating worsened by 1.6.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- MAGENTA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1978.05% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, MAGENTA THERAPEUTICS INC's average analyst price target is higher than 173.14% of them.
- In the context of all US stocks, MAGENTA THERAPEUTICS INC's variance in analysts' estimates is lower than -1589.23% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, MAGENTA THERAPEUTICS INC's number of analysts covering the stock is greater than 555.42% of them.
Stocks similar to MAGENTA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are KZR, XERS, and VRCA.
View All Top Stocks by Price Target
What is the outlook for MGTA? Use POWR Ratings for clearer insight into price direction.